Zobrazeno 1 - 10
of 1 508
pro vyhledávání: ''
Autor:
Marc Carrier, Philip S. Wells, Lana A Castellucci, Aurélien Delluc, Ameeta L. Nayak, Amin Zahrai, Tzu-Fei Wang, Ranjeeta Mallick
Publikováno v:
Thrombosis Research. 208:79-82
Background Apixaban has been shown to significantly decrease the rate of VTE among intermediate-to-high risk patients starting chemotherapy compared to placebo. This investigation sought to determine the impact of apixaban among different subgroups o
Autor:
Ane Abad-Motos, Juan Churruca, Beatriz Mestre-Gómez, Juan Torres-Macho, Juan A. Martín-Navarro, Cristina Cortina-Camarero, Rosa María Lorente-Ramos, Paz Arranz-García, Jacobo Rogado, Nuria Muñoz-Rivas, Pedro Torres-Rubio, Pablo Ryan, Eloy Gómez-Mariscal, Soledad R. Alonso-García, Eva Moya-Mateo, Cristina Mauleón-Fernández, Fernando Sierra-Hidalgo, Teresa Saez-Vaquero, Ana Isabel Franco-Moreno, Jose Angel Hernandez-Rivas, Ana Such-Diaz
Publikováno v:
Thrombosis Research
Background Incidence of thrombotic events associated to Coronavirus disease-2019 (COVID-19) is difficult to assess and reported rates differ significantly. Optimal thromboprophylaxis is unclear. Objectives We aimed to analyze the characteristics of p
Autor:
Jackson King, Ashok Pai, Nathan P. Clark, Daniel M. Witt, Thomas Delate, Malti Charlu, Shiyun Zhu, Jordan B. King
Publikováno v:
Thrombosis Research. 196:367-370
Background First-line treatment and secondary prevention of venous thromboembolism (VTE) in patients with cancer consisted, historically, of unfractionated heparin or low-molecular weight heparin (LMWH). With recent clinical trials of direct oral ant
Autor:
Vibeke Andersen, Corinna Bang, Else-Marie Bladbjerg, Lucas Moitinho-Silva, Claus B. Juhl, Line Espenhain Landgrebe
Publikováno v:
Landgrebe, L E, Juhl, C B, Andersen, V, Moitinho-Silva, L, Bang, C & Bladbjerg, E M 2020, ' Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1 + 2 in patients with morbid obesity ', Thrombosis Research, vol. 196, pp. 260-267 . https://doi.org/10.1016/j.thromres.2020.08.044
Introduction Increased postprandial factor VII activation is observed after high-fat meals, but is not accompanied by thrombin formation in normal weight individuals. Obesity is associated with a higher circulating concentration of tissue factor (TF)
Autor:
Il Young Oh, Ju Hyeon Lee, Seong Soon Kwon, Sangyoung Kim, Yang Ki Kim, Hyeon Jong Yang, Ji Yun Lee, Soo Mee Bang
Publikováno v:
Thrombosis Research. 195:243-249
Introduction Direct oral anticoagulants (DOACs) have the potential to increase bleeding due to drug-drug interactions (DDIs). In the present study, the risk of bleeding was evaluated when drugs with potential DDIs were simultaneously prescribed with
Autor:
Julie Curtin, Yanyan Li, Faraizah Abdul Karim, Claude Negrier, Elena Santagostino, Wilfried Seifert
Publikováno v:
Thrombosis Research. 188:85-89
Introduction Long-acting recombinant factor IX (FIX) products may simplify the surgical treatment of haemophilia B patients. The impact of rIX-FP, a recombinant FIX fused to recombinant albumin, on FIX consumption and surgical management was assessed
Autor:
Zsuzsa Bagoly, Anetta Undas, Agata Hanna Bryk, Elżbieta Broniatowska, Jakub Siudut, Barbara Barath, Éva Katona
Publikováno v:
Thrombosis Research. 185:55-62
Background Type 2 diabetes mellitus (T2DM) is associated with hypofibrinolysis and increased factor XIII-mediated α2-antiplasmin incorporation into the fibrin clot. It is unclear whether there are sex-related differences in α2-antiplasmin incorpora
Autor:
Valentin J. Krieg, Christian Troidl, Stefan Guth, Sebastian Kölmel, Mareike Lankeit, Lukas Hobohm, Stavros Konstantinides, Christoph Liebetrau, Eckhard Mayer, Christoph B. Wiedenroth
Publikováno v:
Thrombosis Research. 185:20-26
Introduction Although a number of risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) have been reported, the exact prevalence is controversial and varies between published cohorts. The aim of the present study was to investigate t
Publikováno v:
Thrombosis Research, 184, 8-15. Elsevier Science
Thrombosis research, Vol. 184, p. 8-15 (2019)
Thrombosis research, Vol. 184, p. 8-15 (2019)
Background: Reliable assays to measure direct oral anticoagulant (DOAC) levels and their activity in critical situations are needed. Drug levels alone are not representative of the effect of DOACs on an individual's coagulation. We developed a techni
Autor:
Jessica Valaize, Pascale Gaussem, Emmanuel Curis, Julien Demagny, Alain Stepanian, Virginie Siguret, Fabienne Nedelec-Gac, Jérôme Duchemin, Maxime Delrue, Isabelle Gouin-Thibault, Luc Darnige, Xavier Delavenne, Georges Jourdi, Geoffrey Foulon-Pinto
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩
Thrombosis Research, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩
Thrombosis Research, Elsevier, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩
Thrombosis Research, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩
International audience; Introduction Lupus Anticoagulant testing using dilute Russell Viper Venom Time (dRVVT) is challenging in patients receiving Direct Oral AntiCoagulants (DOAC) due to potential false positive results. In a multicenter study, we